Oral News and Research

RSS

IV iron dextran alternative to oral iron for anemia in nondialysis CKD

Treatment with intravenous low-molecular-weight iron dextran seems to be an effective alternative for patients with nondialysis chronic kidney disease who remain anemic despite receiving oral iron and erythropoiesis-stimulating agents.

8 Mar 2013

Medication use and doctor visits drive up jaw necrosis-related costs

Long-term medication use and follow-up visits are the main drivers affecting costs associated with cancer-related bisphosphonate-associated osteonecrosis of the jaw, report researchers in Oral Diseases.

8 Mar 2013

Failure to use aspirin before angioplasty increases death rate

Despite recommendations from leading medical groups, a surprising number of patients are not given aspirin before artery-clearing coronary angioplasty and stenting, and those patients have a significantly higher in-hospital death rate, according to research from a Michigan network being presented at the American College of Cardiology's 62nd Annual Scientific Session.

8 Mar 2013

Marc Liechtung provides valuable insight into oral health

Oral health is often the window to your overall health. And some of your daily activities or habits can affect oral health.

7 Mar 2013

FDA accepts AMAG’s Feraheme sNDA for review

AMAG Pharmaceuticals, Inc. today announced that the United States Food and Drug Administration (FDA) has accepted for review the company's supplemental new drug application (sNDA) for Feraheme (ferumoxytol) Injection for Intravenous (IV) use, which was submitted to the FDA in December 2012.

6 Mar 2013

AHRQ releases Making Health Care Safer II report

The Agency for Healthcare Research and Quality (AHRQ) has released a new report, Making Health Care Safer II, which identifies the top 10, evidence-based patient safety strategies available to clinicians.

6 Mar 2013

Women's low adherence to daily-dose products in HIV prevention trial suggest different approach needed, researchers say

"Results of a major HIV prevention trial suggest that daily use of a product -- whether a vaginal gel or an oral tablet -- does not appear to be the right approach for preventing HIV in young, unmarried African women," a press release from the Microbicide Trials Network reports.

6 Mar 2013

SGO's 44th Annual Meeting on Women's Cancer to be held in Los Angeles

Ovarian cancer treatment, health care reform, the impact of obesity on gynecologic health and the delivery of high quality gynecologic cancer care highlight the Society of Gynecologic Oncology's (SGO) 44th Annual Meeting on Women's Cancer March 9-12 in Los Angeles.

6 Mar 2013

Increased pneumonia rates after Japan earthquake

Significantly increased rates of pneumonia and related deaths were seen after the 2011 Earthquake and Tsunami in Tohoku, Japan, report researchers.

5 Mar 2013

Two asthma medications combined in one inhaler more effective than recommended treatment

Two large randomised trials published to coincide with the launch of The Lancet Respiratory Medicine provide compelling new evidence that using two types of common asthma medications combined in one inhaler for both preventive and rescue treatment (Single inhaler Maintenance and Reliever Therapy; SMART) is more effective at reducing attacks than guideline-based treatment in adults whose asthma is not well controlled, and is safe and well tolerated.

5 Mar 2013

Good dental health ‘cuts stroke risk’

Good dental health, including prophylaxis of periodontal disease, is associated with a reduced risk for ischemic stroke, results of a large retrospective cohort study indicate.

5 Mar 2013

Microcystins in drinking water

An interview with Rohan Thakur, discussing the prevalence of microcystins in drinking water, and the use of LC-MS to identify cyanotoxins within water samples.

From Bruker Daltonics 5 Mar 2013

Sanford-Burnham enters into partnership to test furin for treatment of dengue fever

Sanford-Burnham Medical Research Institute and 60- Pharmaceuticals, LLC, have entered into a partnership to test furin, a human proteinase, as a drug target for the treatment of dengue fever, one of the most common infectious diseases in the tropics and subtropics.

5 Mar 2013

Study finds antiretroviral-based strategies to prevent HIV infection among women prove ineffective

Three antiretroviral-based strategies intended to prevent HIV infection among women did not prove effective in a major clinical trial in Africa.

5 Mar 2013

HCV and HIV co-infected patients achieve early treatment success with faldaprevir, PegIFN/RBV

Interim study results from STARTversoTM 4 presented today at CROI+ show that 80 percent of hepatitis C (HCV) patients also infected with HIV achieved early treatment success with faldaprevir (BI 201335) combined with pegylated interferon and ribavirin (PegIFN/RBV).

5 Mar 2013

Positive results from NeuroDerm ND0612 Phase I trial on Parkinson's

NeuroDerm, Ltd. announced today the results of a Phase I safety and pharmacokinetic trial of ND0612, a novel drug formulation for the treatment of Parkinson's disease.

4 Mar 2013

Chroma Therapeutics, CTI announce results from tosedostat Phase 2 study on AML

Cell Therapeutics, Inc. (CTI) and Chroma Therapeutics Ltd. announced today that Lancet Oncology has published results from the OPAL Phase 2 study of tosedostat in elderly patients with relapsed or refractory acute myeloid leukemia (AML).

4 Mar 2013

Tooth loss due to periodontal disease is more prevalent among postmenopausal women

Postmenopausal women who have smoked are at much higher risk of losing their teeth than women who never smoked, according to a new study published and featured on the cover of the Journal of the American Dental Association by researchers at the University at Buffalo.

2 Mar 2013

No increased risk for inflammatory bowel disease with isotretinoin

Researchers report no link between isotretinoin use for the treatment of acne and increased risk for inflammatory bowel disease in women of reproductive age.

1 Mar 2013

Mercury exposure raises diabetes risk later in life

People with a high level of mercury exposure in young adulthood are at an increased risk for developing diabetes later in life, report researchers.

1 Mar 2013

Oral News and Research

IV iron dextran alternative to oral iron for anemia in nondialysis CKD

Medication use and doctor visits drive up jaw necrosis-related costs

Failure to use aspirin before angioplasty increases death rate

Marc Liechtung provides valuable insight into oral health

FDA accepts AMAG’s Feraheme sNDA for review

AHRQ releases Making Health Care Safer II report

Women's low adherence to daily-dose products in HIV prevention trial suggest different approach needed, researchers say

SGO's 44th Annual Meeting on Women's Cancer to be held in Los Angeles

Increased pneumonia rates after Japan earthquake

Two asthma medications combined in one inhaler more effective than recommended treatment

Good dental health ‘cuts stroke risk’

Microcystins in drinking water

Sanford-Burnham enters into partnership to test furin for treatment of dengue fever

Study finds antiretroviral-based strategies to prevent HIV infection among women prove ineffective

HCV and HIV co-infected patients achieve early treatment success with faldaprevir, PegIFN/RBV

Positive results from NeuroDerm ND0612 Phase I trial on Parkinson's

Chroma Therapeutics, CTI announce results from tosedostat Phase 2 study on AML

Tooth loss due to periodontal disease is more prevalent among postmenopausal women

No increased risk for inflammatory bowel disease with isotretinoin

Mercury exposure raises diabetes risk later in life

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

Latest News